3D graphic showimg a CAR T cell killing a cancer cell
3D graphic showimg a CAR T cell killing a cancer cell
Logo

CAR T cell manufacturing and TCR engineering at clinical scale

Automate and standardize your engineered T cell manufacturing process in a closed system setup. The CliniMACS Prodigy® Platform streamlines the entire workflow, from cell separation and activation to engineering and final formulation and filling, all within a fully integrated system that offers the flexibility to adapt to your specific process needs.

Advancing engineered T cell manufacturing

The development of chimeric antigen receptor (CAR) T cell therapies has transformed the treatment of hematological cancers, as well as infectious and autoimmune diseases.1-5 At the same time, TCR engineering opens new possibilities by targeting intracellular antigens, broadening treatment options for solid tumors and infectious diseases.4-6 Together, they are shaping the future of autologous and allogeneic therapies, unlocking off-the-shelf treatment solutions that reduce immune rejection, cytokine release syndrome, and other serious adverse events.7,8

Despite their potential, advanced cell therapies come with complex manufacturing requirements, the need for robust quality control, and high regulatory standards. At Miltenyi Biotec, we support you with automated, closed-system workflows and integrated analytics that bring consistency, efficiency, and reproducibility to T cell manufacturing for clinical applications.

From starting material to final product

Infographis showing a mixture of different cells in a cell culture bag

Starting material

Built for versatility, the platform processes a wide range of sources, from fresh or frozen leukapheresis products to whole blood and PBMCs, increasing feasibility and enabling flexible logistics.
Infographis showing a mixture of different cells in a cell culture bag

Starting material

Built for versatility, the platform processes a wide range of sources, from fresh or frozen leukapheresis products to whole blood and PBMCs, increasing feasibility and enabling flexible logistics.
Infographic demonstrating the magnetic field for column based magnetic cell sepataion

Separation

Efficient magnetic cell separation yields a highly pure starting T cell population for reliable downstream processing (e.g., efficient transduction).
Infographic demonstrating the magnetic field for column based magnetic cell sepataion

Separation

Efficient magnetic cell separation yields a highly pure starting T cell population for reliable downstream processing (e.g., efficient transduction).
Infographic showing the activation T cells

Activation

T cells are stimulated using, e.g., MACS® GMP T Cell TransAct™, or user-defined reagents in bags, supporting optimal activation for subsequent gene modifications.
Infographic showing the activation T cells

Activation

T cells are stimulated using, e.g., MACS® GMP T Cell TransAct™, or user-defined reagents in bags, supporting optimal activation for subsequent gene modifications.
Infographic showing viral transduction of a cell in a process generating CAR T cells

Gene engineering

Genetic modification is performed using viral transduction, either with lentiviral or retroviral vectors, enabling flexibility for complex editing.
Infographic showing viral transduction of a cell in a process generating CAR T cells

Gene engineering

Genetic modification is performed using viral transduction, either with lentiviral or retroviral vectors, enabling flexibility for complex editing.
Infographic showing the expansion of CAR T cells

Expansion

Standard and large-scale expansion supported by two cultivation chamber sizes, with fully adjustable culture settings to optimize the cell growth or shorten the manufacturing time.
Infographic showing the expansion of CAR T cells

Expansion

Standard and large-scale expansion supported by two cultivation chamber sizes, with fully adjustable culture settings to optimize the cell growth or shorten the manufacturing time.
Infographic showing the formulation unit of the CliniMACS Prodigy

Formulation and filling

Automated formulation and filling enables consistency in final product preparation and quality control samples, supporting infusion-ready or cryopreservation-compatible outputs.
Infographic showing the formulation unit of the CliniMACS Prodigy

Formulation and filling

Automated formulation and filling enables consistency in final product preparation and quality control samples, supporting infusion-ready or cryopreservation-compatible outputs.
Infographic showing CAR T cells in a cell culture bag

Final cell product

The result: A high-quality, gene-engineered T cell product formulated to meet desired dose and volume specifications.
Infographic showing CAR T cells in a cell culture bag

Final cell product

The result: A high-quality, gene-engineered T cell product formulated to meet desired dose and volume specifications.
Infographis showing a mixture of different cells in a cell culture bag

Starting material

Built for versatility, the platform processes a wide range of sources, from fresh or frozen leukapheresis products to whole blood and PBMCs, increasing feasibility and enabling flexible logistics.
Infographis showing a mixture of different cells in a cell culture bag

Starting material

Built for versatility, the platform processes a wide range of sources, from fresh or frozen leukapheresis products to whole blood and PBMCs, increasing feasibility and enabling flexible logistics.
Infographic demonstrating the magnetic field for column based magnetic cell sepataion

Separation

Efficient magnetic cell separation yields a highly pure starting T cell population for reliable downstream processing (e.g., efficient transduction).
Infographic demonstrating the magnetic field for column based magnetic cell sepataion

Separation

Efficient magnetic cell separation yields a highly pure starting T cell population for reliable downstream processing (e.g., efficient transduction).
Infographic showing the activation T cells

Activation

T cells are stimulated using, e.g., MACS® GMP T Cell TransAct™, or user-defined reagents in bags, supporting optimal activation for subsequent gene modifications.
Infographic showing the activation T cells

Activation

T cells are stimulated using, e.g., MACS® GMP T Cell TransAct™, or user-defined reagents in bags, supporting optimal activation for subsequent gene modifications.
Infographic showing viral transduction of a cell in a process generating CAR T cells

Gene engineering

Genetic modification is performed using viral transduction, either with lentiviral or retroviral vectors, enabling flexibility for complex editing.
Infographic showing viral transduction of a cell in a process generating CAR T cells

Gene engineering

Genetic modification is performed using viral transduction, either with lentiviral or retroviral vectors, enabling flexibility for complex editing.
Infographic showing the expansion of CAR T cells

Expansion

Standard and large-scale expansion supported by two cultivation chamber sizes, with fully adjustable culture settings to optimize the cell growth or shorten the manufacturing time.
Infographic showing the expansion of CAR T cells

Expansion

Standard and large-scale expansion supported by two cultivation chamber sizes, with fully adjustable culture settings to optimize the cell growth or shorten the manufacturing time.
Infographic showing the formulation unit of the CliniMACS Prodigy

Formulation and filling

Automated formulation and filling enables consistency in final product preparation and quality control samples, supporting infusion-ready or cryopreservation-compatible outputs.
Infographic showing the formulation unit of the CliniMACS Prodigy

Formulation and filling

Automated formulation and filling enables consistency in final product preparation and quality control samples, supporting infusion-ready or cryopreservation-compatible outputs.
Infographic showing CAR T cells in a cell culture bag

Final cell product

The result: A high-quality, gene-engineered T cell product formulated to meet desired dose and volume specifications.
Infographic showing CAR T cells in a cell culture bag

Final cell product

The result: A high-quality, gene-engineered T cell product formulated to meet desired dose and volume specifications.

Tailored flexibility with harmonized workflows

The CliniMACS Prodigy Platform integrates every step of T cell manufacturing into an automated, closed system, providing workflows adapted for diverse therapeutic demands.

  • T Cell Transduction (TCT): The gold standard in CAR T cell manufacturing, using high-efficiency viral transduction for robust gene delivery.
  • T Cell Transduction and Automated Formulation (TCTf): Adds formulation and filling flexibility to the TCT workflow, enabling precise control over final product preparation.
  • T Cell Transduction – Large Scale (TCT-LS): Expands the TCT workflow to accommodate larger culture volumes, supporting higher-dose approaches and large-scale manufacturing needs.

Designed to support GMP-compliant workflows, these processes enable automated, standardized manufacturing of gene-engineered T cells. By reducing manual handling and open steps, these processes deliver reproducible T cell production for clinical application.9

Compare workflows: Key features and specifications

 TCTTCTfTCT-LS
Main applicationCAR T cells for hematologic malignancies
and autoimmune diseases
CAR T cells for hematologic malignancies
and autoimmune diseases
TCR-engineered and CAR T cells for solid tumors
Starting materialFresh leukapheresis products
Whole blood, PBMCs
Fresh or frozen leukapheresis products
Whole blood, PBMCs
Fresh or frozen leukapheresis products
Gene engineering methodTransduction via lentivirus or retrovirusTransduction via lentivirus or retrovirusTransduction via lentivirus or retrovirus
Final T cell count (within 12-day process)Approx. 5 × 109 T cellsApprox. 5 × 109 T cellsUp to 20 × 109 T cells
Necessary instrumentsCliniMACS ProdigyCliniMACS Prodigy and Formulation UnitCliniMACS Prodigy
Automated formulation and fillingHarvest into one product bag in fresh formulationSplit up to 8 product bags with fresh or cryopreservation-ready formulationHarvest into one product bag in fresh formulation solution
Process specifications and
required materials at a glance
TCT application sheetTCTf application sheetTCT-LS application sheet

Get personalized support for your manufacturing workflow of clinical-grade CAR T cells and TCR-engineered cells

Efficient manufacturing in five steps

Each workflow follows the same structured process. The steps below outline how the CliniMACS Prodigy supports standardized, automated cell manufacturing while enabling GMP-compliant workflows.

1. T cell separation

Infographic demonstrating the magnetic field for column based magnetic cell sepataion

High-purity T cells are essential for successful gene engineering, as contaminating cell types can interfere with genetic modifications.

The CliniMACS Prodigy Platform reliably isolates functional T cells, even from challenging starting materials such as patient-derived or frozen samples. Using magnetic separation technology, it delivers consistent results with high precision, eliminating the need for bead removal and reducing manual effort.

Dot plots showing T, B, NK, NKT, monocyte, and granulocyte frequencies in enriched samples from healthy and patient donors.
Enriched cell populations

Consistent T cell enrichment across donor types

Enrichment is consistent across fresh and frozen material from both healthy donors and patients.

2. T cell activation

Infographic showing the activation T cells

Prepare T cells for engineering with MACS® GMP T Cell TransAct™, a proven reagent for consistent and robust activation. Available in standard and large-scale formats, it provides optimal activation performance.

Flow cytometry data shoring CD25⁺CD69⁺ T cell activation after stimulation with standard- and large-scale TransAct.
T cell activation at day 2 post-stimulation

Potent T cell activation with MACS GMP T Cell TransAct

Strong and reproducible activation achieved in both TCT and TCT-LS processes.

3. Gene engineering

Infographic showing viral transduction of a cell in a process generating CAR T cells

Viral transduction enables the efficient gene delivery. For retroviral transduction, addition of MACS GMP Vectofusin®-1 significantly enhances transduction efficiency.

Use QC-controlled, off-the-shelf lentiviral vectors compatible with the CliniMACS Prodigy to support consistent transduction.

Dot plot showing frequencies of CAR⁺ and TCR⁺ T cells after transduction of T cells activated for 24 hours.
Efficiency of gene transfer

Efficient transduction of CAR and TCR constructs

CAR and TCR constructs are transferred with high efficiency.

4. T cell expansion

Infographic showing the expansion of CAR T cells

Efficient expansion in a closed system with controlled culture conditions supports both CAR T cell production process and advanced TCR engineering.

  • Programmable culture phase settings allow for optimized medium exchange schedules and shaking options to shape the desired end product.
  • Optimization can increase the yield or shorten manufacturing time, e.g., 7-day processes for faster clinical manufacturing and cost savings.10,11
  • Synergistic tools like TexMACS™ GMP Medium and MACS GMP Cytokines provide optimal consitions for cell growth.

Details on the 7-day manufacturing process are available in our application note on CAR T cell generation from cryopreserved leukapheresis products.

Line graph showing expansion of CD4⁺CD8⁺ T cells over 12 days in standard- and large-scale CliniMACS Prodigy cultures using IL-2 or IL-7/15
T cell expansion kinetics

Efficient T cell expansion

Robust growth achieved from fresh and frozen leukapheresis products under various cytokine conditions.

Viability of CD4⁺CD8⁺ T cells over 12 days in standard- and large-scale CliniMACS Prodigy cultures with IL-2 or IL-7/15.
T cell viability during expansion

High T cell viability during expansion

T cells maintain high viability throughout cultivation, regardless of starting material or cytokine.

5. Harvest, formulation, and filling

The CliniMACS® Formulation Unit, together with the TCTf workflow, automates formulation and filling, preparing cells for infusion or cryopreservation.

  • Fully programmable to support various formulation and filling scenarios, including single-bag and multi-bag setups.
  • Supports fresh or cryopreservation-ready products while maintaining product consistency.
  • Closed system operation reduces contamination risks.12,13

For specialized needs, our Customized Application Services can create tailored workflows to meet requirement not addressed by our off-the-shelf solutions.

Dot plot showing T cell subset frequencies in final product after expansion in standard- or large-scale CliniMACS Prodigy.
T cell subset composition in final products

Consistent T cell subset distribution after expansion

TCT and TCT-LS processes yield comparable T cell phenotypes in the final product.

Quality control testing by flow cytometry

Researcher in clean room attire is starting an analysis on the flow cytometer MACSQuant Analyzer 16

In order to enable safe and consistent cell manufacturing, the implementation of robust in-process control and release testing (IPC/RT) is crucial.

Samples collected within the manufacturing process, e.g., on the CliniMACS Prodigy, are reliably analyzed on our standardized flow cytometry platform. Our comprehensive workflow solution comprises harmonized MACSQuant® Flow Cytometers, automated data acquisition and analysis (Express Modes) in an audit-ready software, and a broad portfolio of REAfinity® Recombinant Antibodies with superior specificity and reproducibility. Miltenyi Biotec provides complete solutions with time saving and standardized staining procedures with StainExpress™ Dry Antibody Cocktails, sensitive and lot-to-lot consistent CAR or TCR Detection reagents, and options for cytokine multiplexing.

Dot plots of flow cytometry analysis using the StainExpress CD19 CAR T Transduction Cocktail for CAR T detection in IPC/QC clinical assays.
Standardized CAR T cell analysis

Automated analysis of CAR T cells

Standardized and reproducible analysis of CAR T cells achieved with the MACSQuant Analyzer and Express Modes, supporting efficient QC workflows.

Miltenyi Biotec Perfect Match CliniMACS Prodigy and MACSQuant Analyzer 16 cell manufacturing and analytics

Integrated solution for manufacturing and analytics

The CliniMACS Prodigy and MACSQuant Flow Cytometers form the perfect match for integrated cell manufacturing and analytics, providing a customizable workflow that reduces variability and supports reproducible, high-quality results.

Tailored services & programs

Custom Application Services

Our off-the-shelf workflows are built for flexibility and cover most cell manufacturing needs. For highly specific requirements, our Custom Application Services team can help translate your manual protocols into a tailored, streamlined workflow on the CliniMACS Prodigy.

Learn more

Cell manufacturing enabling package (CMEP)

Miltenyi’s modular training and support program helps teams move from project launch to GMP-compliant clinical production in as little as 12 months. With proven protocols, GMP documentation templates, and expert guidance, the CMEP streamlines every step of implementation.

Learn more

Selected references: Leveraging the CliniMACS Prodigy Platform for engineered T cell manufacturing

Icon selected references in turquoise

Read more about how your peers have used our platform for CAR T cell manufacturing for solid tumors or autoimmunity, for TCR-engineered T cell generation and viral or non-viral engineering strategies.

Get personalized support for your manufacturing workflow of clinical-grade CAR T cells and TCR-engineered cells

Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use. For complete regulatory notes, please click here.

You have previously chosen International as your location.
What do you want to do?